NCPA supports two pieces of legislation reintroduced in the Senate Thursday that will bring transparency to PBMs. Sens. Maria Cantwell (D-Wash.) and Chuck Grassley (R-Iowa) are reintroducing the PBM Transparency Act (S. 127), and the Prescription Pricing for the People Act (S. 113). “We’re grateful to Sens. Cantwell and Grassley for continuing fighting to pull back the curtain on PBMs and push for FTC review of anticompetitive PBM practices,” said Anne Cassity, NCPA’s senior vice president of government affairs, in response to the reintroduction of the bills.
The 118th Congress is getting busy at the Capitol – and that means NCPA’s Advocacy team members Anne Cassity, senior vice president, government affairs, and Adam Harbison, senior director, Congressional affairs, are on the Hill too, meeting new members, greeting returning members, and working to recruit more independent pharmacy champions.
Dear Colleague, Two out of three Americans are hopeful that 2023 will be a better year than 2022, according to a survey by the marketing firm, Ipsos. In a short video message in Tuesday's qAM, the first of the new year, I took a brief look back at 2022, recounting some of the success community pharmacy enjoyed over the year just past. Now, nearly a week into 2023, I want to take a look into some things to look for in 2023.